Ramesh Ponnuru


Media Fellow, Hoover Institution; Senior Editor, National Review.

Filter By:



Recent Commentary

Healthcare warning
Analysis and Commentary

A Market-Based Contingency Plan For King V. Burwell

by Lanhee J. Chen, James C. Capretta, Yuval Levin, Ramesh Ponnuru, Joseph Antos, Thomas Miller, Avik Roy, Gail R. Wilensky, David Wilsonvia Health Affairs
Monday, June 15, 2015

If the Supreme Court rules in favor of the plaintiffs in the King v. Burwell case, Congress will have the opportunity to advance health care policies that expand consumer choice, increase coverage, deliver better value for the dollar, and allow state governments more say over health care policy.

Stem Cells: The Case for Bush’s Policy

by Ramesh Ponnuruvia Hoover Digest
Saturday, October 30, 2004

The case against federal funding of stem-cell research. By Ramesh Ponnuru.

A LINE IN THE TEST TUBE: The Debate over Stem Cells

with Ramesh Ponnuru, Irving Weissmanvia Uncommon Knowledge
Monday, September 20, 2004

Proponents of embryonic stem cell research proclaim the potential of the research to find cures or treatments for many diseases such as Parkinson's and Alzheimer's. Opponents say the use and destruction of human embryos in the conduct of this research are immoral. In 2001, President Bush announced a ban on federal funding involving any new lines of embryonic stem cells. But calls to lift the ban continue, as do movements to increase funding at the state level. Which side of the debate is right? Is embryonic stem cell research ethical or not? Peter Robinson speaks with Ramesh Ponnuru and Irving Weissman.

Stock Market Democrats

by Ramesh Ponnuruvia Policy Review
Sunday, October 1, 2000

Ramesh Ponnuru on Bull Run: Wall Street, the Democrats, and the New Politics of Personal Finance by Daniel Gross